Cargando…
Perceived Stigma of Patients Undergoing Treatment with Cannabis-Based Medicinal Products
Cannabis-based medicinal products (CBMPs) are prescribed with increasing frequency. This study aimed to investigate the perceived stigma attached to patients prescribed CBMPs in the UK to establish its prevalence. A qualitative survey was developed by an expert multidisciplinary group and data were...
Autores principales: | Troup, Lucy J., Erridge, Simon, Ciesluk, Beata, Sodergren, Mikael H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223559/ https://www.ncbi.nlm.nih.gov/pubmed/35742748 http://dx.doi.org/10.3390/ijerph19127499 |
Ejemplares similares
-
Medical cannabis, CBD wellness products and public awareness of evolving regulations in the United Kingdom
por: Erridge, Simon, et al.
Publicado: (2022) -
Clinical Outcome Data of Children Treated with Cannabis-Based Medicinal Products for Treatment Resistant Epilepsy—Analysis from the UK Medical Cannabis Registry
por: Erridge, Simon, et al.
Publicado: (2023) -
Clinical outcome data of anxiety patients treated with cannabis-based medicinal products in the United Kingdom: a cohort study from the UK Medical Cannabis Registry
por: Rifkin-Zybutz, Raphael, et al.
Publicado: (2023) -
Real World Evidence in Medical Cannabis Research
por: Banerjee, Rishi, et al.
Publicado: (2021) -
Clinical Outcome Data of First Cohort of Chronic Pain Patients Treated With Cannabis‐Based Sublingual Oils in the United Kingdom: Analysis From the UK Medical Cannabis Registry
por: Kawka, Michal, et al.
Publicado: (2021)